dr. galsky discusses progression in patients with metastatic bladder cancer
Published 6 years ago • 1.4K plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
0:59
dr. galsky on progression on immunotherapy in bladder cancer
-
2:03
dr. galsky on targeted therapies in bladder cancer
-
1:36
dr. galsky discusses neoadjuvant immunotherapy in bladder cancer
-
0:59
dr. galsky on resistance to checkpoint blockade in metastatic bladder cancer
-
1:20
dr. galsky on the role of ipilimumab for the treatment of bladder cancer
-
1:35
matthew galsky gives an overview of bladder cancer
-
1:58
dr. galsky discusses combination immunotherapy in bladder cancer
-
44:28
breakthroughs in bladder cancer immunotherapy, with matthew galsky
-
1:07
dr. galsky on ipilimumab in bladder cancer
-
2:19
dr. galsky discusses the rationale for the imvigor130 study in bladder cancer
-
1:53
discussing recent advances and clinical trials in bladder cancer
-
1:09
dr. galsky on the role of ipilimumab in bladder cancer
-
1:40
the rationale behind checkmate-275 in metastatic bladder cancer
-
1:03:24
bladder cancer: understanding immune-, targeted-, and antibody-based models for patient care
-
1:35
dr. matthew galsky on pfs as an endpoint in urothelial cancer trials
-
2:21
dr. galsky on maintenance pembrolizumab in urothelial cancer
-
1:54
targeted therapy effective for patients with advanced bladder cancer and specific gene mutations
-
1:10
the difficulties in treating bladder cancer with immunotherapy
-
1:08
matthew galsky, md, shares a message for patients regarding clinical progress in bladder cancer